Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress MAR001, a ...
Evidence for Vitamins and Nutrition in Cardiovascular Disease? EAS 2007: The goal of using diet and dietary supplements to treat cardiovascular risk and disease continues to motivate serious study -- ...
Be part of the 84TH EAS Congress (EAS 2016) and gain access to an outstanding scientific programme focused on the latest topics and discoveries in the field of atherosclerotic disease. With unique ...